Abstract
Intraoperative fluorescence imaging (IFI) can improve real-time identification of cancer cells during an operation. Phase I clinical trials in thoracic surgery have demonstrated that IFI with second window indocyanine green (TumorGlow®) can identify subcentimeter pulmonary nodules, anterior mediastinal masses, and mesothelioma, while the use of a folate receptor-targeted near-infrared agent, OTL38, can improve the specificity for diagnosing tumors with folate receptor expression. Here, we review the existing preclinical and clinical data on IFI in thoracic surgery.
Original language | English (US) |
---|---|
Pages (from-to) | 344-355 |
Number of pages | 12 |
Journal | Journal of Surgical Oncology |
Volume | 118 |
Issue number | 2 |
DOIs | |
State | Published - Aug 1 2018 |
Keywords
- OTL38
- indocyanine green (ICG)
- intraoperative fluorescence imaging (IFI)
- near-infrared (NIR) fluorescence imaging
- thoracic surgery
ASJC Scopus subject areas
- Surgery
- Oncology